Notifications
Clear all
Topic starter
18/07/2020 7:43 pm
Case report:
https://www.lemmo.com/wp-content/uploads/2019/03/Mistetloe-Ovarian-Cancer-Case-Report-2019.pdf
On a personal note, my wife´s sister is doing mistle toe (helixor M) since february 2020 after finishing her second platinum-based chemotherapy (recurrence in 2019, DX October 2016, Ovarian stage IV, mets to liver). She had a PET scan a week ago and is cancer-free right now.
Topic starter
19/07/2020 12:32 am
Here's another case report indicating synergistic cytotoxic and proliferation-inhibiting effects of chemotherapy + mistletoe combination in Ovarian cancer:
